The company stated that no generic versions of semaglutide are currently available and described compounded alternatives as "unapproved fake or illegitimate knockoffs" that could "expose patients to serious safety and efficacy risks." As part of their effort to address this issue, Novo Nordisk has advocated for semaglutide to be added to the FDAs list of drugs that present "demonstrable difficulties for compounding." FDAs Decision and Timelines In February, the FDA declared that the semaglutide shortage was officially over
As diabetes medications and weight loss medications like Ozempic, Wegovy, and Mounjaro have become more popular, many women have expressed concern about the possibility of female-specific side effects
At Aliva Weight Loss in Hilliard, OH, Dr
Using the same examples: These results have attracted considerable attention because they begin approaching the levels of weight loss historically associated with bariatric surgery
Were talking about potential reductions in blood glucose of around 10-15%, not the 30-50% drops some social media posts suggest